Light therapy developer Apira Science Inc. has received clearance from Anvisa, the Brazilian regulatory agency for cosmetics and health services, to sell and distribute its iGrow Hair Growth System in Brazil.

iGrow is an FDA-approved, wearable, home-use laser device that uses low-level light therapy (LLLT) to aid in hair growth. In clinical studies, the iGrow’s patented red light technology, which consists of a highly productive combination of red laser and LED diodes, increased hair growth 37 percent after 16 weeks of therapy and nearly doubled total hair growth 10 weeks faster than handheld laser combs and brushes.

Apira Science and distributor Onderma will distribute the iGrow in Brazil. The country represents the second largest hair care market in the world, after the U.S., and the third largest consumer market for beauty products overall. In 2014, women alone spent more than $7.7 billion on hair care.

“Brazilian men and women alike dedicate much time, effort and money into maintaining healthy hair,” said Jeff Braile, president of Apira Science. “By achieving Anvisa clearance for the iGrow and partnering with Onderma, we’re giving consumers in this country a clinically proven LLLT treatment to fight hereditary hair loss and grow thicker, healthier hair.”

Apira is a developer of light-based beauty solutions.